Life Sciences industry leader joins the region’s Life Science & Healthcare membership organisation
Cambridge, UK: 10 April 2024
A Supportive Membership Offer While You Plan Your Next Step
Being made redundant, or finding yourself between roles for any reason, can be an unsettling time. It can also be an important moment to reconnect with your professional community, explore new opportunities, and invest in your next step.
Sandwich, UK — 4 November 2026: Discovery Park, Kent’s science and innovation hub, has launched the eighth edition of its Discovery Spark accelerator programme, welcoming 10 startups to its campus in Sandwich.
The Budget on 28 October 2026, the first under the new Prime Minister and John Healey’s first as Chancellor, left the rates of R&D tax relief unchanged and announced two changes to how claims are made. Companies making R&D claims on or after 1 April 2027 will no longer have to submit a Claim Notification Form, and the Additional Information Form will be simplified from autumn 2027. Alongside the Budget, HM Treasury opened a consultation on simplifying the corporate tax rules, R&D relief among them.
Bidwells' Creative Places team has appointed Sue Foxley and Harry Blevins, strengthening its research capability and London science and technology leasing offer as the business continues to grow.
Sue will be joining the Creative Places team on a part-time basis, to focus on leading edge research and data trends in science and technology as well as providing valuable insight to clients on ecosystem strategy through Creative Places consultancy mandates. Sue will continue to lead the Research function across the Bidwells Group.
*Guest article by Singular Talent Limited. If you would like to submit an article or blog post please email [email protected].
If you’ve been hiring recently, you’ll have noticed that generating applications is easy. If you just need warm bodies with basic qualifications, it’s a great time to grow your team.
Common Synapse has just published The Unprompted Patient Journey – Patient Intelligence Report 2026, bringing together 3,835 public patient, caregiver and clinician narratives from six studies across eight neuro-related conditions.
Read the report here:
https://commonsynapse.com/case-studies/CommonSynapse_The_Unprompted_Patient_Journey_2026.pdf
We are seeking a Discovery DMPK Scientist (Senior Scientist II / Principal Scientist depending on experience). You will be part of a dynamic and innovative environment and will become an integral part of our vision to address patients’ unmet needs while building Britain’s Biggest Biotech. You will use your DMPK expertise and scientific curiosity to solve drug discovery challenges, as part of multi-disciplinary project teams. You will be able to work in state-of-the-art laboratory and modern facilities for optimum collaboration alongside a focused and caring team.
Life science has become a networked industry. As companies grow, capital often scales faster than internal teams, while the capability that matters most – from commercial expertise and manufacturing to regulatory knowledge and international access - increasingly sits with partners rather than on the payroll.
So what does that mean for leadership?